WeGene Personal Genome Service Test

$ 99


Ancestry Composition
  • • Ancestry Composition
  • • Maternal Haplogroup
  • • Paternal Haplogroup
  • • Neanderthal Ancestry
Genetic Health Risk
  • • Late-Onset Alzheimer's Disease *
  • • Genetic risk for a form of dementia
  • • 1 variant in the APOE gene; variant found and studied in many ethnicities

There is a lot to consider with personal genome service test. We encourage you to review relevant information about ancestry and Genetic Health Risk reports on the Test information page.

只需 1mL 唾液,您就可以轻松在家获取个人基因检测报告,包括祖源、健康、营养、运动、美肤、心理等九大类,近 500 项官方报告全面解读(具体报告数以实际检测为准), 提供 PDF 版报告且承诺终身免费更新,全方位探索独一无二的自己。

作为专业的基因检测服务公司,WeGene 采用自主研发、专为中国人群设计的 CGA 科研级基因芯片——不仅显著提升中国群体的数据解读性,覆盖全新临床数据库,可用于针对性探索遗传性状及疾病,还兼容国际合作研究,能快速跟进同步最新科研成果。配合经 FDA 认证的 DNA Genotek 进口唾液采集管,严格把控每一个细节的质量,确保您的数据可靠和安全。

WeGene 检测标准版 3.0 还根据您的基因数据,提供体检、营养、保险等个性化健康服务,更高效地改善生活,为您的健康保驾护航。

回寄有效期:12 个月(为最大程度保证样品质量,请在购买后 12 个月内完成样本的采集、绑定和回寄)

Service steps


Register your collection kit


Mail it back

Discover your reports

Why WeGene

We aim to let people with East Asians ancestry benefit from knowing and understanding their genomic data.

The saliva collection kit

We use FDA-cleared saliva collection device for reliable, non-invasive collection, stabilization and transportation of high quality DNA.

Custom genotyping chip

We use custom designed lllumina iSelect array solutions, powered by BeadArray and Infinium technologies, provide trusted performance for genotyping your DNA.

*The WeGene Personal Genome Service test includes genetic health risk reports. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Warnings & Limitations: The WeGene Personal Genome Service Genetic Health Risk Report for Late-Onset Alzheimer’s Disease is indicated for reporting of the ε4 variant in the APOE gene. The report describes if a person has variants associated with a higher risk of Late-Onset Alzheimer’s Disease. This report does not include variants in other genes linked to Late-Onset Alzheimer’s Disease and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact Alzheimer’s Disease risk. The Personal Genome Service test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit https://www.wegene.com/en/intro/